| Subject: | FDA Actions To Reduce Overdose Risk With Pain Medications Containing Propoxyphene |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Tue, 28 Jul 2009 - 06:00 am |
| The Food and Drug Administration (FDA) has recently taken several actions to reduce the risk of overdose in people who use pain medications, such as Darvon and Darvocet. These medications contain the drug propoxyphene, which is linked to death from overdoses. The FDA finds there is evidence that propoxyphene can effectively treat pain at recommended doses. But because of the drug's potential risks, the agency is requiring manufacturers to provide more information to help physicians and... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
